Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
about
New Molecular Insights of Insulin in Diabetic CardiomyopathyMolecular and Cellular Mechanisms of Cardiovascular Disorders in DiabetesUric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceDiabetic cardiomyopathy: where we are and where we are going.Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy.Association of blood glucose level and hypertension in Elderly Chinese Subjects: a community based studyLoss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance.Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award LectureSensory and autonomic function and structure in footpads of a diabetic mouse model.Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.Apigenin alleviates STZ-induced diabetic cardiomyopathy.The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart.Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Effects of Silymarin on Diabetes Mellitus Complications: A Review.Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.Complications of Diabetes 2016Exosomes: A Rising Star in Falling Hearts.Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration.The relationship between insulin sensitivity and heart rate-corrected QT interval in patients with type 2 diabetes.SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury.The Mitochondrial Lon Protease Is Required for Age-Specific and Sex-Specific Adaptation to Oxidative Stress.Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I.Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy.CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.Metabolomics reveals new metabolic perturbations in children with type 1 diabetes.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.Gaseous signalling molecule SO2 via Hippo‑MST pathway to improve myocardial fibrosis of diabetic rats.The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
P2860
Q26752678-280AF7D4-3B35-4936-B07D-1B33DBD946EFQ28395675-BA64C8BD-4055-4054-9407-2A5DD33F2195Q33577406-8747C453-8E9B-4CD2-86C9-9E618C61DA8FQ33644666-98AE7FEC-347F-4E00-8C0D-09E26C4A4B8AQ33690717-3A1E4AFA-C6FE-4F67-9296-BB0F35C62C57Q33882472-3B8D2178-2456-4422-9A61-3DE035467D76Q36076636-C7EC4D94-15EE-4BD6-9C37-675A0D9E9768Q36119524-80CB4F07-B866-4B1E-B5A6-2F636A118EA8Q36930826-0278606F-A94E-4EEF-A0D3-16FFD69DC499Q37609577-D784245B-C172-462E-A0B8-96A24ED59949Q37700844-FF8E5726-5E75-45AB-B343-86F066DF3508Q37718230-A8AA45A7-EBC0-4FE6-9AE3-372A8E2DECAAQ38374511-B281CC87-F070-4C99-B417-56991B83BA00Q38378534-6BA17D5E-FBDA-46DF-A37E-9099EC86ADADQ38642356-0B2A29DE-9ECF-460B-92DC-A0B954239BE5Q38717398-57DEB4A6-F33A-4B8C-AEBF-4B7D5C963691Q38791358-23A872F2-6D10-4A83-BBB0-91E7949AA14EQ38813231-CA227671-5574-436B-9BF0-19D4F4AD6A2CQ38947643-A577F3E7-4095-4C31-950A-30DAE761C2E4Q38974621-8CD7CD5A-B824-4C92-AC97-C011072B4EF5Q38998120-8536E46F-13F1-4C9A-BFDF-E2CC024B998EQ39042819-C5C2D598-65A3-4A6A-91A8-36B5F54295C3Q39198039-D1802E2C-5FCA-4C2E-9678-7D9CCC451C56Q39256900-8015FECC-97CD-4014-8020-8FF6B3FFEDADQ40485268-EC8C8CB2-7EA7-4516-883F-D9C7281BE3BBQ41001027-12577154-2CEF-4669-9E46-FAF9C5950A41Q41169113-9FAFF75D-B5F1-4B4A-993E-A07C625AAC25Q41281402-A8ABDB71-FB0C-49B2-8427-5D8F03172F88Q41528591-13DA5694-A47B-4A72-A5C7-2F26C378B83DQ44024892-41691FF2-204E-420E-B06A-395F63486B69Q45986289-CC026F34-01BF-4394-8620-13A63F6D20B1Q46185793-F2A01E21-F38E-46D5-8864-C1359E7D23FEQ46201938-98F24249-EF10-46D0-B85F-8820C8E374C1Q47111423-E45718D6-F72C-46EE-AA42-4B38F24173B6Q47265749-A49FA8AE-AA70-4BC9-BC03-EBFF6C560274Q47285651-4C6CE4EA-EE32-484D-B75A-8349A6DC480EQ47396427-6F1ABB5A-35E7-4DB6-AA5E-C7067CD5736FQ47649685-859BE479-6F0A-451A-9EF0-2E6E1938FE77Q47679777-54694B6B-9DBF-4840-BB39-442774748074Q47788950-75CD3CDB-33A5-4772-B706-1BFA0E10F901
P2860
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@ast
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@en
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@nl
type
label
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@ast
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@en
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@nl
prefLabel
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@ast
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@en
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@nl
P2860
P3181
P356
P1476
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
@en
P2093
Guanghong Jia
James R Sowers
P2860
P2888
P304
P3181
P356
10.1038/NRENDO.2015.216
P407
P577
2016-03-01T00:00:00Z
P6179
1051707210